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Introduction
Satellite cells are the proper stem cells of the adult skeletal muscle. 
Like other stem cell types, these cells are maintained over very long 
time periods (1, 2). Despite their characterization as early as 1961, 
satellite cells have only been recognized recently as indispensable 
for muscle regeneration (3–5). Satellite cells are notoriously diffi-
cult to study due to their low abundance and their dispersed loca-
tion in the specific stem cell niche, the space between basal lamina 
and sarcolemma of skeletal muscle. Recent animal experiments 
have allowed deeper insight into the function and regulation of 
satellite cells (2, 6–9). The studies indicated that satellite cells 
have an enormous potential for self-renewal and superb potential 
for muscle regeneration. However, expansion of human satellite 
cells for therapeutic purposes has not been successful. Therefore, 
therapy-oriented research has favored the use of other cell popu-
lations with myogenic potential, such as CD133+ cells, pericytes, 
inducible stem cells, mesoangioblasts, or PW1 cells (10–14). These 
cells are abundant, more accessible, and transverse blood vessels. 
However, compared with satellite cells, such alternative cell types 
have limited ability to form muscle stem cells (satellite cells) and 
to regenerate muscle tissue.
Satellite cells appear during development, and their differen-
tiation and survival depends on the paired box proteins PAX3 and 
PAX7 (2). While PAX3 plays a key role in embryonic satellite cell 
development, PAX7 predominantly directs their postnatal survival 
(15, 16). PAX7 is expressed postnatally and is a reliable satellite 
cell marker (17). Additional markers like CD56 (NCAM), CD34, 
CXCR4, m-cadherin, α7-integrin, MET, syndecan-3, and synde-
can-4 characterize murine muscle satellite cells (18–22), but their 
relevance for the identification of human satellite cells has not 
been established. After skeletal muscle injury, quiescent satellite 
cells become activated and either self renew or enter a differen-
tiation program that culminates in fusion to the syncytial muscle 
fiber. Several factors and pathways drive this complex cascade, 
including myogenic regulatory factors (such as MYF5, MYOD, and 
myogenin) and signaling systems (such as WNT and NOTCH) as 
well as yet ill-defined factors provided by the extracellular matrix 
or systemic sources (reviewed in ref. 23).
Early transplantation studies demonstrated a promising 
contribution of mouse myoblasts to regeneration of host fibers 
in the mdx mouse model of Duchenne’s muscular dystrophy 
(24). Shortly thereafter, clinical trials were conducted and were 
based on the injections of cultured postnatal human myoblasts 
into muscle of patients with Duchenne’s muscular dystrophy. 
Unfortunately, transplanted myoblasts showed poor survival, low 
ability to migrate, and made little contribution to fiber regener-
ation (25–27). The aim of our study was to develop tools to ren-
der human muscle stem cells manageable for research on muscle 
regeneration and for gene therapy in muscular dystrophies and 
other muscle-wasting disorders.
Muscle satellite cells promote regeneration and could potentially improve gene delivery for treating muscular dystrophies. 
Human satellite cells are scarce; therefore, clinical investigation has been limited. We obtained muscle fiber fragments 
from skeletal muscle biopsy specimens from adult donors aged 20 to 80 years. Fiber fragments were manually dissected, 
cultured, and evaluated for expression of myogenesis regulator PAX7. PAX7+ satellite cells were activated and proliferated 
efficiently in culture. Independent of donor age, as few as 2 to 4 PAX7+ satellite cells gave rise to several thousand myoblasts. 
Transplantation of human muscle fiber fragments into irradiated muscle of immunodeficient mice resulted in robust 
engraftment, muscle regeneration, and proper homing of human PAX7+ satellite cells to the stem cell niche. Further, we 
determined that subjecting the human muscle fiber fragments to hypothermic treatment successfully enriches the cultures 
for PAX7+ cells and improves the efficacy of the transplantation and muscle regeneration. Finally, we successfully altered 
gene expression in cultured human PAX7+ satellite cells with Sleeping Beauty transposon–mediated nonviral gene transfer, 
highlighting the potential of this system for use in gene therapy. Together, these results demonstrate the ability to culture and 
manipulate a rare population of human tissue-specific stem cells and suggest that these PAX7+ satellite cells have potential to 
restore gene function in muscular dystrophies.
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3-month-old child but were not present on muscle sections from 
adult donors. Occasionally, we identified CD34+ or CXCR4+ cells 
in adult muscle specimens or muscle fiber preparations, but these 
did not costain for PAX7 and were not located in the satellite cell 
niche. Therefore, these markers were not used further to iden-
tify satellite cells in humans (Supplemental Figure 2). We subse-
quently refer to PAX7+ cells as human satellite cells.
Culture of HMFFs. We next tested whether satellite cells in 
HMFFs are viable and can be cultured. In cultured HMFFs, cells 
remained motile for up to 10 days (Supplemental Video 1). During 
the first days of culture, satellite cells remained associated with 
the fiber and did not grow out on the culture dish. Instead, they 
associated with the remaining scaffold of the fiber fragment and 
located inside the fiber, in which they were densely packed. After 
5 to 10 days, the cells moved out of the fiber onto the culture dish 
and formed the first colonies.
During the time that PAX7+ cells remained associated with cul-
tured fibers (5–10 days), their number increased considerably, and 
we estimated a 20- to 50-fold increase in quantity compared with 
that of freshly prepared fragments (Figure 2A). The majority of 
such cells were desmin+, and many were MYF5+/desmin+ (Figure 2, 
A and B), indicating that they correspond to activated satellite 
Results
PAX7+ satellite cells on freshly isolated human muscle fiber fragments. 
We obtained 69 different specimens of fresh muscle tissue from 
adult human subjects (age 20–80 years, 34 female and 35 male 
donors) after due approval and written, informed consent. Human 
muscle fiber fragments (HMFFs) were dissected manually, with-
out enzymatic treatment (Figure 1 and Supplemental Figure 1; sup-
plemental material available online with this article; doi:10.1172/
JCI63992DS1). We isolated and analyzed 884 fragments contain-
ing 1–8 fibers (Supplemental Table 1). We used various antigens 
previously characterized in mice to identify human satellite cells 
in freshly isolated HMFFs. Coimmunostaining for PAX7 and the 
neural cell adhesion molecule NCAM (CD56) (Figure 1B) reliably 
identified cells associated with the human fibers. The majority 
(80%) of these were double positive for PAX7 and NCAM, but we 
also observed similar proportions of cells staining either only for 
PAX7 or only for NCAM. Rarely, MYF5+/PAX7+ cells were found 
(Figure 1B). 2% to 4% of all nuclei in skeletal muscle fibers were 
PAX7+. We noted no major differences in the proportion of PAX7+ 
nuclei associated with fibers in different age groups. We also tested 
other markers, such as MET, CXCR4, and CD34. MET+ cells were 
abundant in a skeletal muscle biopsy specimen obtained from a 
Figure 1. Characterization and propa-
gation of freshly isolated HMFFs. (A) 
Experimental design. Different designs 
are numbered I–V. (I) 580 HMFFs from 
50 skeletal biopsy specimens. (II) 304 
HMFFs from 19 biopsy specimens. (III) 
272 HMFFs from 19 biopsy specimens. 
(IV and V) 33 transplantations from 6 
biopsy specimens. (B) Freshly isolated 
HMFFs. PAX7+/NCAM+ satellite cells are 
present on freshly isolated HMFFs (top 
row) (green: PAX7+; red: NCAM+; blue: 
Hoechst stain). A differential interfer-
ence contrast image is shown to the 
right. MYF5+/PAX7+ cells are identified 
on HMFFs after 5 days of tissue culture 
(bottom row). Scale bar: 20 μm.
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The fraction of nonmuscle cells (desmin– cells) in the colonies var-
ied between 5% and 25% and, on rare occasions, was as high as 
70%. However, the proportion was not higher in HMFF cultures 
from aged donors.
Growth factors and substrate rigidity are important for sat-
ellite cell maintenance and proliferation (28). Matrigel contains 
a mixture of matrix proteins and growth factors, and Matrigel-
coated substrates are used frequently for cultures of mouse myo-
genic cells. We compared HMFFs cultured on culture plastic with 
or without Matrigel for 7 to 14 days and observed neither obvi-
ous differences in the formation of colonies outside the fiber nor 
changes in the colony size (Supplemental Figure 3). Thus, the 
scaffold provided by the fibers themselves suffices to stimulate ini-
tial activation and proliferation of satellite cells, independent of 
external factors provided by Matrigel. Culture conditions without 
additives like Matrigel will be advantageous in experiments with 
cells used for retransplantations into patients.
cells. Activation of satellite cells, as assessed by the appearance of 
large groups of PAX7+ and desmin+ cells, was observed in 100% of 
the cultured HMFFs, independent of the age of the donors. After 
3 weeks of culture, the numbers of PAX7+ (but not desmin+) cells 
associated with the HMFFs declined, indicating that the myogenic 
cells began to differentiate (Figure 2A). The basal lamina provided 
an outer shell for the HMFFs in culture (Figure 2C).
We also analyzed cells that no longer associated with the 
fiber and had formed a colony on the culture dish (Figure 3A, top 
row). In 2-week-old HMFF cultures, the number of such cells was 
always high, and we observed colonies containing around 1,000 
to 2,000 cells. The cells in these colonies were heterogeneous, i.e., 
usually most were desmin+. Some had fused into myotubes, and 
the proportion of PAX7+ cells was variable (10%–50%), even when 
the HMFFs were obtained from the same donor (Figure 3A, mid-
dle row). BrdU pulse labeling (22 hours) confirmed that many cells 
(50%) in the colonies were proliferating (Figure 3A, bottom row). 
Figure 2. Activated satellite cells proliferate within the HMFFs. (A) Marked proliferation of PAX7+ cells is observed in HMFFs, independent of the age of 
the donors. During the first 10 days of HMFF culture, approximately 80% of cells within the fiber fragment were PAX7+ (green: PAX7, red: desmin, blue: 
Hoechst dye). At day 21, the quantity of PAX7+ cells within the HMFFs is reduced to 10% of HMFF myoblasts. (B) Myoblasts within HMFF cultures are 
MYF5+ after 14 days (green: desmin, red: MYF5, blue: Hoechst). (C) The basal lamina (β2-laminin, green) ensheathes desmin+ cells (red) in the HMFFs  
(14 days of culture). Scale bar: 50 μm. Illustrations in A and C depict HMFFs. MSC, muscle satellite cells.
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with 18 Gy, engraftment of human myoblasts was readily observed 
3 or 7 weeks after transplantation (Figure 4). At the earlier time 
point, myotubes and myofibers containing human nuclei were 
detectable, but human nuclei were more abundant in muscle fibers 
7 weeks after transplantation. Occasionally, murine and human 
nuclei were present in hybrid myofibers (Figure 5B). The size of the 
largest dissemination of human nuclei was 800 × 400 × 400 μm.
Hypothermic treatment of HMFFs enriched cultures for myogenic 
cells and improved transplantation efficacy. We next tested whether 
HMFFs used as a source for satellite cells are storable, which would 
be advantageous for autologous transplantation and gene repair 
experiments. Glucose-containing buffered salt solution (Solution 
A) did not permit survival of muscle stem cells. However, when we 
kept HMFFs at 4°C in medium with low serum (OptiMEM) (hypo-
thermic treatment) without oxygenation for as long as 35 days and 
subsequently cultured them at 37°C and 21% oxygen (experimen-
tal design III in Figure 1A and Figure 3C), we detected satellite cell 
colonies outgrowing the fiber. Hypothermic treatment resulted 
in delayed formation of colonies on the culture dishes, i.e., the 
first colonies were observed after 2 weeks, and some colonies 
appeared only after 6 weeks of HMFF culture. Remarkably, colo-
nies from HMFFs subjected to hypothermic treatment contained 
100% myogenic cells (desmin+ cells) (Figure 3D). Thus, nonmyo-
genic cells like fibroblasts did not survive prolonged storage at 
hypothermic conditions. Although the colonies only consisted of 
myogenic cells, they were heterogeneous, containing PAX7+ cells 
(between 20% and 60%), cells that express MYF5 and MYOD, 
and frequently fusing myotubes (Figure 3D). After BrdU labeling, 
colonies from HMFFs subjected to hypothermic treatment and 
freshly obtained HMFFs displayed similar labeling indices.
Freshly isolated HMFFs always gave rise to colonies, but, 
after hypothermic treatment, outgrowth was more variable and 
myoblasts grew only from 50% of HMFFs. Colony formation 
after hypothermia and hypoxia did not correlate with donor age. 
Hypoxia is known to activate NOTCH signaling, and NOTCH is 
known to be important for satellite cell maintenance (29–31). The 
presence of DAPT, a γ-secretase and NOTCH signaling inhibitor, 
during hypothermic treatment did not interfere with survival of 
satellite cells, and we observed similar colony sizes and numbers 
of PAX7+ cells in HMFF cultures regardless of the presence or 
absence of the inhibitor during storage at 4°C (Figure 3D).
We then tested whether HMFFs after hypothermic/hypoxic 
treatment could be transplanted successfully. HMFFs were kept 
at 4°C for 3 weeks, placed into 37°C tissue culture for 2 weeks, and 
Sleeping Beauty–based gene transfer can be applied to HMFF sat-
ellite cells. We then tested whether gene delivery can be achieved 
in satellite cells in cultured HMFFs. Muscle fiber fragments were 
cultured for 2 days and then cotransfected with a Sleeping Beauty 
transposon–based vector encoding the fluorescent protein Venus 
(pT2-CAGGS-Venus) and a second expression plasmid encoding 
the CMV-SB100X transposase. Venus+ satellite cells were visible 
1 day after transfection. After these cells had moved onto the culture 
dish, Venus+ myoblasts were present for up to 35 days (Figure 3B).
Satellite cells from HMFFs contribute to muscle regeneration after 
engraftment into mice. Next, we transplanted HMFFs into anterior 
tibialis muscles of NOG mice (n = 33). For transplantation, we used 
HMFFs cultured for 5 to 7 days, i.e., fibers containing activated sat-
ellite cells that had not yet left the fiber. We transplanted HMFFs 
from biopsy specimens obtained from 6 donors (aged 44–64 years) 
(Table 1, experimental groups A–D). When fibers were transplanted 
into nonirradiated muscle or into muscle irradiated with 9 Gy, few 
human nuclei were present 3 or 8 weeks after the transplantation, 
as assessed by the presence of human lamin A/C detected by an 
anti-human–specific lamin A/C antibody. Almost all human lamin 
A/C+ nuclei were located in the interstitium and not integrated in 
the muscle fibers (Figure 4). After focal irradiation of the muscle 
Figure 3. Cell colonies originating from HMFF cultures contain satellite 
cells and retain normal proliferative and fusion capacity. (A) Four HMFFs 
after 14-day tissue culture on Matrigel (green: desmin, blue: Hoechst). 
Large colonies of desmin+ cells are found as well as spontaneously fused 
multinucleated myotubes (top row). Scale bar: 200 μm (first and second 
image); 50 μm (third image). Approximately 50% of cells are PAX7+ satel-
lite cells after 19 days in culture (red: PAX7, green: desmin, blue: Hoechst) 
(middle row). Scale bar: 20 μm. At 19 days of tissue culture, BrdU staining 
(red: BrdU, green: desmin, blue: Hoechst) confirms that myogenic cells are 
proliferating (bottom row). Scale bar: 20 μm. The asterisk indicates a divid-
ing PAX7+ cell. (B) Sleeping Beauty transposon–mediated gene transfer of 
a Venus transgene (pT2-caggs-Venus). Venus expressed in satellite cells 
(top image). Venus+ cells form colonies outside the HMFF (middle and bot-
tom images). Scale bar: 200 μm. The double asterisks indicate HMFF. (C) 
Cell colonies from HMFF cultures after 35 days of hypothermic treatment 
in serum-reduced medium (OptiMEM) and subsequent culture in SMGM at 
37°C for 32 days (left). Solution A did not permit cells to survive hypo-
thermic treatment (right). Scale bar: 200 μm. The double asterisks indicate 
HMFF. (D) Myogenic cells derived from HMFFs after 35 days of hypothermic 
treatment followed by 27 days (BrdU, PAX7, MYF5) and 48 days (MYOD, 
desmin) in SMGM at 37°C. Desmin stain demonstrates a pure myogenic 
population without contaminating fibroblasts. PAX7-desmin double stain 
after HMFFs were placed in 15 μM DAPT during hypothermic treatment (21 
days). PAX7+ cells were abundant after 35 days at 37°C. Scale bar: 50 μm.
Table 1. Transplantation of HMFFs into NOG mice






Human cells  
after 3 weeksC
Human cells after  
7 to 8 weeksC
Multinuclear human  
fibers, PAX7+ cells
A 44 f, 47 f No 9/10 No 5–150 5–150 No
B 53 m No 1/3 9 5–50 n.t. No
C 53 m, 64 f No 8/10 18 5–300 5–300 Few
D 62 m, 64 m ht for 3 weeks 6/10 18 5–150 n.t. Frequent
AAge in years and gender; Btransplants with human cells per total number of transplanted tibialis anterior muscles; Cnumber of human nuclei per 
cryosection. f, female; m, male; n.t., not tested; ht, hypothermic treatment.
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then transplanted into mouse tibialis anterior muscles. Analysis 
3 weeks after transplantation revealed that the transplants had par-
ticipated in muscle regeneration more efficiently than HMFFs with-
out hypothermic treatment. Muscle fibers in the transplants con-
tained more and multiple human nuclei (Figure 4 and Figure 5A). 
Further, human lamin A/C+ cells that coexpressed PAX7 were 
detected in a satellite cell position below the lamina (Figure 5B). 
A quarter of the human nuclei were PAX7+ in one section of one 
transplant. Only very few human nuclei were detected in the 
interstitium. Lack of nonmyogenic cells like fibroblasts might 
account for this difference.
Discussion
We investigated a long-term tissue culture model to define prop-
erties and growth characteristics of human satellite cells that 
remained associated with muscle fibers (HMFF culture). We pro-
vide a detailed characterization, beginning with the quiescent sat-
ellite cell located in the stem cell niche, their subsequent activa-
tion, migration, and differentiation. We show that enrichment and 
expansion of satellite cells is feasible, that cultured human fiber 
fragments can be transplanted and contribute to muscle regener-
ation, and that they generate human satellite cells that home cor-
rectly to the satellite cell niche. Further, using transposon-medi-
ated gene insertion into the genome (Sleeping Beauty System), 
gene delivery was accomplished in satellite cells in cultured fibers.
Simple expansion of satellite cells in culture results in rapid 
differentiation, and the cell population with self-renewal and 
regenerative potential is rapidly lost (32). Others have used sus-
pensions of cultured human primary satellite cells (myoblasts) 
in transplantation experiments; however, such transplanted cells 
survive poorly and do not contribute to fibers. We show here that 
cultured and transplanted HMFFs can fuse to muscle fibers and 
participate in the endogenous stem cell pool, indicating that fiber 
culture overcomes the previous limitations of cultured human pri-
mary satellite cells (myoblasts).
Recent work has provided important insight into satellite 
cell biology, revealing molecular mechanisms that might help 
to expand and maintain such stem cells. For instance, culture of 
murine satellite cells on soft hydrogel substrates rather than rigid 
plastic enriches cultures for a self-renewing stem cell population 
with improved regenerative efficacy (28). The HMFF culture sys-
tem introduced here provides a 3-dimensional environment with a 
soft matrix and shows that satellite cells in vivo also use damaged 
fibers as scaffolds during regeneration.
In addition to satellite cells, HMFFs contain other cell types like 
fibroblasts. In accordance, colonies from freshly cultured HMFFs 
also contain nonmyogenic cells, but such nonmyogenic cells are 
not longer observed when HMFFs are stored for prolonged periods 
at 4°C prior to culture. Quiescent stem cells survive under extreme 
conditions, for instance, in postmortem tissue (33) or under hypoxic 
microenvironments (reviewed in ref. 29). Metabolic requirements 
of quiescent satellite cells appear distinct from those of activated 
stem cells or from other cell types, such as fibroblasts. The long-
term survival of satellite cells and their enrichment will be advanta-
geous in cell replacement or gene therapy approaches, as they imply 
the option of storing the muscle fibers for several weeks.
We found that gene transfer can be applied successfully to 
cultured satellite cells, which are associated with HMFFs. We 
documented the delivery of a Venus cDNA gene using the Sleep-
ing Beauty transposon system. Transposons can be considered to 
Figure 4. Transplantation of HMFFs into NOG mice. Anterior tibial muscles of NOG mice were transplanted with 4 to 8 HMFFs. Human cells were 
detected with anti-human lamin A/C antibody (yellow). Transplantation of HMFFs without prior irradiation resulted in human cells located interstitially 
in the host tissue (group A, Table 1). Three weeks after irradiation with 18 Gy and transplantation of HMFFs, fusing human myotubes were identified 
(group B). Seven weeks after transplantation, human myofibers had formed (group C). HMFFs transplanted after hypothermic treatment (ht) resulted in 
large human myofibers that contained multiple human nuclei (group D). Scale bar: 200 μm (top row); 50 μm (bottom row, first, third, and fourth images); 
20 μm (bottom row, second image). 
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represent natural gene delivery vehicles. Transposon-based tools 
are versatile and can be used in gene therapy (34, 35). SB100X-
mediated gene transfer allows stable, long-term gene expression 
in various primary cells and stem cells and functions over a broad 
range of cDNA size. Thus, transposon-based gene transfer might 
be suitable for deliver transgenes that encode very large muscle 
proteins, such as the full-length dysferlin or dystrophin, into cells 
that are transplanted into skeletal muscle.
Local irradiation was a prerequisite for successful engraftment 
and for participation of transplanted cells in muscle regeneration. 
Endogenous stem cells in the healthy muscles of the recipients are 
damaged by this procedure, indicating that the transplanted cells 
only contribute to regeneration when endogenous stem cells are 
impaired. In contrast to other protocols, apart from a small mus-
cle incisure, into which the HMFF fragments were deposited, no 
additional damage, like freeze trauma or cardiotoxin, was applied. 
Future experiments will be required to assess whether multiple 
small injuries combined with HMFF transplantation will suffice 
to efficiently deliver cells into larger muscle groups. It is notewor-
thy that in the most efficient transplants observed, every fiber in 
the damaged and regenerating area contained a human nucleus. 
Restoration of 10% gene activity could be sufficient for therapy in 
muscular dystrophies, indicating that the participation of trans-
planted cells observed here might already be beneficial.
Human satellite cells are scarce and can currently not be iso-
lated by FACS. Indeed, the low number of satellite cells in HMFFs 
would not allow sorting, even if a suitable surface marker were 
available. Cultured HMFFs containing satellite cells might pro-
vide starting material for autologous cell transplantation for treat-
ment of muscular dystrophies, provided that efficient gene deliv-
ery can be achieved. We observed that HMFFs obtained from all 
adult subjects analyzed here contained human satellite cells that 
could be expanded in culture. Autologous satellite cells provide an 
advance over nonautologous cell sources (for instance, satellite 
cells obtained from human cadavers, ref. 33), circumventing dif-
ficulties associated with obtaining tissue or the life-long require-
ment of immunosuppressant after allotransplantation.
Autologous transplantation of HMFFs after correction of the 
disease-causing mutation may not overcome all known disadvan-
tages of myoblast transplants, such as lack of direct access to spe-
cific muscle groups (e.g., diaphragm) or lack of alternative delivery 
routes that are precluded by the inability of the delivered cells to 
Figure 5. Characterization of HMFFs, after and without prior hypothermic treatment, transplanted into 18 Gy irradiated tibialis anterior muscle. (A) 
Nuclei positive for human lamin A/C are readily detected in regenerating muscle fibers after transplantation of freshly prepared HMFFs (yellow: lamin A/C, 
red: desmin). Interstitial nuclei are also present in some abundance. After hypothermic treatment, muscle fibers containing multiple human nuclei were 
identified frequently. Interstitial human nuclei were not present when HMFFs were transplanted after hypothermic treatment. Scale bar: 10 μm (first col-
umn); 50 μm (second column); 20 μm (third and fourth columns). (B) Occasional fibers display both human and murine nuclei (arrows), indicating mouse/
man chimeras (7 weeks after transplantation). PAX7+ human cells are found in their anatomical niche (3 weeks after transplantation). Scale bar: 10 μm.
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minutes and incubated in 1% BSA/PBS for 45 minutes; frozen sections 
were incubated in 5% normal goat serum/PBS for 45 minutes. Primary 
antibodies were used as described in Supplemental Table 2 and incu-
bated for 4 to 16 hours at 4°C. After washing, samples were incubated 
with secondary antibodies (Cy3-conjugated anti-rabbit, Cy3-conju-
gated anti-rat, Alexa Fluor 488–conjugated anti-mouse antibodies, 
each 1:1,000) and Hoechst 1(:1,000) for 45 minutes in 1% BSA/PBS at 
room temperature. Alternatively, UEA (1:100, Vector Labs) was used 
for staining of endothelial layers of capillaries. For PAX7 staining, mus-
cle sections were incubated in preheated antigen-unmasking Vector 
buffer (80°C, Vector Labs) for 15 minutes, fixed in Zamboni fixative 
(PFA/picric acid, pH 7.3) for 20 minutes, and, after additional washing, 
incubated in blocking buffer (10% horse serum, 0.5% blocking reagent 
[PerkinElmer], 0.1% Triton X-100 in PBS). Subsequently, sections were 
incubated with anti-PAX7 hybridoma supernatant for 12 hours. Sections 
were washed in PBS/0.1% Triton X-100 and incubated with fluores-
cence-conjugated secondary antibodies for 30 minutes. Samples were 
imaged with a Leica DMI 6000 (Leica Microsystems) or a Zeiss LSM 
700 confocal microscope (Carl Zeiss MicroImaging GmbH). Images 
were composed and edited in Photoshop CS (Adobe) or CorelDRAW 
X5. 3-dimensional visualization of z-stacks was performed with Amira 
(Visage Imaging). As a rule, all modifications were applied to the whole 
image. Time-lapse microscopy was performed with a Leica DMI 6000 
in a humidified atmosphere at 37°C and 5% CO2. All antibodies and 
dilutions are listed in Supplemental Table 2.
Focal irradiation of tibialis anterior muscle. Female 6-week-old NOD.
Cg-Prkdcscid Il2rgtm1Sug/JicTac mice (referred to as NOG mice herein) 
(Taconic) were anesthetized with ketamine-xylazine in PBS (9 mg/ml 
ketamine, 1.2 mg/ml xylazine) with a dose of 160 μl/20 g administered 
by intraperitoneal injection. To provide a reproducible position for the 
mice, an acrylic glass block with surface fiducial markers was constructed. 
For the calculation of digitally reconstructed radiographs (DRRs) as 
well as for treatment planning, a computed tomography (CT) scan, with 
0.75-mm slice thickness, was conducted with a dedicated CT scanner 
(Siemens Emotion). This CT data set served as an exemplary basis for 
calculation of the DRRs, for tracking, and for radiation dose distribution, 
assuming all legs and muscles of the selected mice were similar. The CT 
volume data set was used for target delineation of the murine body as 
organ at risk. The prescription dose was 18 Gy, as earlier proposed by 
Boldrin et al. (36). Because of the inherent inhomogeneity of dose dis-
tribution, a maximum of 19.5 Gy was accepted in the targeted leg, with 
the 90% isodose line completely enclosing the target region. All mice 
were treated with a single irradiation fraction of 18 Gy using the image-
guided robotic system (CyberKnife Radiosurgery System, Accuray Inc.) 
(Supplemental Figure 4). The mice were placed in the customized acrylic 
mold with attached fiducial markers. The fiducial markers were used for 
superimposing the live positioning images during the treatment proce-
dure with previously calculated radiograms. The 3-dimensional correc-
tion values were used by the robotic treatment couch. The treatment 
procedure itself could be conducted within a 5-minute time span.
Transplantation of HMFFs into murine tibialis anterior muscle. Mice 
were placed under anesthesia using ketamine-xylazine (9 mg/ml ket-
amine, 1.2 mg/ml xylazine) with a dose of 160 μl/20 g. Anterior tib-
ial muscles were cut longitudinally, and HMFFs (4–8 muscle fibers) 
were placed inside the muscle parallel to the orientation of the murine 
fibers. The tibialis anterior muscles were closed without sutures. The 
overlying skin was closed using polyglycolic acid threads (MARLIN 
migrate across vessels. Indeed, we observed limited migration of 
human cells from the insertion site after muscle transplantations 
of HMFFs. This state of affairs is similar to the restricted dispersal 
of transplanted cells described in previous experiments that used 
different sources of satellite cells/myoblasts and transplantation 
protocols. It is possible that local application of autologous human 
satellite cells combined with intravenous application of other cell 
types, such as CD133+ cells that possess the capacity for transves-
sel migration, will provide a route to more efficient therapies of 
muscular dystrophies.
Methods
Patients and materials. HMFFs were prepared from muscle specimens 
obtained during hip surgery from individuals without neuromuscu-
lar disorders or for diagnostic purposes (ethical approval EA1/203/08, 
Charité). In total, 1,156 fiber bundles from 69 subjects were analyzed. 
Donor age ranged from 20 to 80 years; 34 were men and 35 were women. 
Analysis of frozen sections included an additional biopsy specimen 
(3 months of age) taken for diagnostic purposes after permission.
Preparation of single HMFF cultures. Immediately after biopsy, 
the muscle specimen was transferred into Solution A, which contains 
30 mM HEPES, 130 mM NaCl, 3 mM KCl, 10 mM d-glucose, and 
3.2 μM Phenol red (pH 7.6). Dissection of single fiber fragments was 
performed mechanically using miniature forceps under a stereomi-
croscope (Leica Microsystems). Secondary bundles were dissected 
by cutting the perimysial fascia, followed by the dissection of primary 
bundles in the same way. Primary bundles were carefully loosened to 
obtain single fibers. Single fiber fragments of a length of 2 to 3 mm were 
further mechanically relieved of connective tissue. HMFFs were either 
placed on Matrigel-coated (BD Biosciences) coverslips or cultured in 
regular plastic dishes. HMFFs were cultured in Skeletal Muscle Growth 
Medium (SMGM, PromoCell) supplemented with 10% FCS, glutamax, 
and gentamicin and cultured in a humidified atmosphere containing 
5% CO2 at 37°C. For characterization of fresh single fibers, isolated 
fiber fragments were fixed in 4% PBS-buffered formaldehyde imme-
diately after mechanical dissection. Staining of freshly prepared mus-
cle fibers was initiated within 45 minutes after the biopsy was taken. 
HMFF cultures were set up within 2 hours after the biopsy procedure or 
subjected to hypothermic treatment. In hypothermic treatment, mus-
cle specimens were placed in Solution A or in serum-reduced optimized 
minimal essential medium (OptiMEM, PromoCell) and deposited at 
4°C for up to 35 days. The stored muscle was not specifically aerated.
Sleeping Beauty–based gene transfer to HMFFs. Gene delivery stud-
ies were performed using the hyperactive Sleeping Beauty transpo-
sase SB100X (32). Cotransfection of HMFFs with a Sleeping Beauty 
transposon–based vector encoding the fluorescent protein Venus 
(pT2-CAGGS-Venus) and an expression plasmid for CMV-SB100X 
transposase was performed 2 days after isolation in SMGM. 400 ng 
pT2-CAGGS-Venus vector and 20 ng SB100X were diluted in 75 μl 
jetPRIME buffer (Polyplus-transfection SA) mixed with 2 μl jetPRIME 
reagent (Polyplus-transfection SA), incubated for 15 minutes at room 
temperature, and added to fiber cultures. Twelve hours after transfec-
tion, the medium was replaced by fresh SMGM. Analyses were per-
formed between 1 and 35 days after transfection.
Immunohistochemistry. For immunohistochemical staining, mus-
cle cryosections (6 μm) were fixed in 3.7% formaldehyde. HMFFs and 
cultured myoblasts were permeabilized in 0.2% Triton X-100 for 10 
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violett HR22, USP 4/0, EP 1.5 threads; Catgut GmbH). For assessment 
of the transplants, tibialis anterior muscle was cut horizontally in the 
middle, and every tenth section into the upper and lower part of the 
muscle was stained for human lamin A/C and desmin.
Study approval. The internal review board of Charité approved the 
study, and written, informed consent was obtained from all partici-
pants (EA1/203/08 and EA2/041/10). Animal studies were performed 
under license G0016/13.
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